Skip to main content

gallium ga 68 gozetotide

Generic: Gallium Ga 68 Gozetotide

gallium ga 68 gozetotide: 2 clinical trials tracked.

gallium ga 68 gozetotide evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about gallium ga 68 gozetotide, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Hepatocellular Carcinoma

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (2)

An International Prospective Open-label, Multi-center, Randomized, Non-comparative Phase II Study of Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) Alone and Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) in Combination With Androgen Receptor Pathway Inhibitors in Patients With PSMA PET Scan Positive Castration-Resistant Prostate Cancer

NCT05849298Registry updated 2026-09-11·Phase 2
Active, not recruiting

Primary endpoint: PSA response

InterventionalRandomizedopen49 enrolledStarted 2024-01Completion 2026-1231 sites · Brazil, Canada, Czechia, France…Novartis Pharmaceuticals

Early Detection, Accurate Staging, and Biologic Characterization of HCC With Hybrid 68Ga-PSMA-Dual -Contrast PET/MRI and PET/CT Using Cyclotron-Produced 68Ga

NCT04762888Registry updated 2026-08-12·Phase 2
Completed

Primary endpoint: Number of HCC Lesions With High PSMA Uptake on Baseline 68Ga-PSMA-11 PET

Interventionalopen52 enrolledStarted 2021-02Completion 2025-061 site · United StatesMayo Clinic